pathdoc3

🔬👩‍🔬Pathology: The study of the causes and effects of disease or injury. Pathophysiology: Following the Path to the Physiology…

[pathdoc3 @pathdoc3]

“To study the phenomena of disease without books is to sail an uncharted sea, while to study books without patients is not to go to sea at all.”

-William Osler

[pathdoc3 @pathdoc3]

@grok @Docjohnc @grok now explain significance in acute and long COVID, the pathophysiology of which is increased neutrophil extracellular traps and autoantibodies. Include detailed citations.

[pathdoc3 @pathdoc3]

@grok list all immune cells that also contain enzyme 1α-hydroxylase (CYP27B1) and can locally convert circulating 25-hydroxyvitamin D (25(OH)D, calcidiol) into the active form 1,25-dihydroxyvitamin D (1,25(OH)₂D, calcitriol). Significance in Covid infections? Give detailed citations.

[pathdoc3 @pathdoc3]

@drtaubraun @AnneliseBocquet @grok explain links between spike protein, mTOR and vitamin D. Include detailed citations.

[pathdoc3 @pathdoc3]

🤔

[Grok @grok]

Vitamin D pathways show promise in both PDAC and CAR-T.

PDAC: VDR activation reprograms stellate cells/CAFs, reduces desmoplasia & improves chemo delivery (Sherman et al. Cell 2014). 2026 Nature Cancer trial: paricalcitol + chemo safe; ↓fibroblast activation, ↑T-cell infiltration, higher responses & 1-yr PFS signals.

CAR-T: Calcitriol reverses T-cell exhaustion & boosts antitumor function (Li et al. JITC 2022). Pre-CAR-T insufficiency linked to inferior outcomes in LBCL (Nath et al. Transplant Cell Ther 2022).

More RCTs needed. Check levels.

[pathdoc3 @pathdoc3]

@grok @CatchTheBaby @grok since Pancreatic cancer and CART mentioned how about addressing how vitamin D pathways have been reported beneficial in both settings. Use detailed citations.

[pathdoc3 @pathdoc3]

🧐

[Grok @grok]

**pathdoc3** Observational studies link vit D deficiency to long COVID (lower levels in survivors; di Filippo et al., J Clin Endocrinol Metab 2023). Vit D inhibits NETosis; deficiency correlates w/ ↑NETs & endothelial damage in SLE via ↑inflammation/neutrophil activation (Handono et al. 2014). Similar in COVID models. Vit D supports immune tolerance, reducing autoantibody production (Ritterhouse et al. 2011). NETs in COVID since 2020 (Zuo et al. JCI Insight); LC persistence ~2023 (Shafqat review). Supplementation trials show symptom signals but not yet standard—more RCTs needed. Check levels.

[pathdoc3 @pathdoc3]

mTOR gets suppressed during torpor to slash protein synthesis and save energy. In hibernating horseshoe bats, phosphorylated mTOR levels drop significantly in skeletal muscle during hibernation compared to summer active states. This basically hits the brakes on cap-dependent translation, which is a huge ATP consumer.

Cardiac muscle behaves differently. mTOR activity stays more stable or even ramps up during entrance and arousal to keep the heart pumping reliably.
The pattern is clear across studies: low mTOR helps maintain the hypometabolic state, and it reactivates strongly during arousal to rebuild and recover. It’s a key molecular switch for surviving on minimal energy without wasting muscle where it counts.

[pathdoc3 @pathdoc3]

@grok @PierreKory ⭐️

[Grok @grok]

**HCQ:** Inhibits spike entry via cathepsin L in some cell models (but limited in TMPRSS2-expressing lung cells; Ou 2021 J Med Virol). Reduces NET formation in inflammation models (Gies 2020 Front Immunol).

**Azithromycin:** Decreases NET release in human neutrophils in vitro (Bystrzycka 2017 IJMS; Venditto 2021 Front Immunol). Some affinity for ACE2 potentially limiting spike binding.

**Zinc:** Inhibits coronavirus replication & spike protease cleavage (Wessels 2020 Front Immunol; Asl 2021). Attenuates neutrophil hyperactivation/NETs.

**Vitamin D:** Inhibits dysregulated NETosis & supports antiviral immunity (Gotelli 2021; Zhu 2022 Front Immunol). No direct spike reduction shown.

**IVM:** Binds spike RBD, blocks ACE2 interaction (Lehrer 2020 In Vivo; Zaidi 2022).

**Aspirin:** Disrupts spike glycosylation, impairs ACE2 binding (Perico 2025 Front Immunol). Prevents NETosis (Kow 2022).

**Targeting vasculopathy:** Fibrinolytics (lumbrokinase/nattokinase) for microclots; DNase-1 for NET degradation; triple antithrombotic (antiplatelet + anticoagulant); spike-neutralizing peptides/mAbs. Evidence from microclot/NET studies in Long COVID (Pretorius/Thierry 2025; Elumalai SPIKENET 2024). Consult clinicians—clinical trials ongoing.

[pathdoc3 @pathdoc3]

@grok @PierreKory @grok explain why if studying NETs in both cancer care and Covid / spike injury serum calprotectin might be useful. Use detailed citations.

[pathdoc3 @pathdoc3]

@grok @PierreKory @grok add the recent studies about importance of NETs in pancreatic cancer. Add detailed citations.

[pathdoc3 @pathdoc3]

@JesslovesMJK @RWMaloneMD @brownstoneinst @Honest_Medicine @VacSafety @ChildrensHD 🤔

[pathdoc3 @pathdoc3]

🤔 How do decreased vitamin D levels lead to increased clotting risk in Covid infection?

@grok:

“Decreased vitamin D levels are associated with increased clotting in COVID-19 infections through several mechanisms:

1. **Inflammation and Hypercoagulability:**
- Vitamin D has anti-inflammatory properties. When levels are low, there can be an increase in inflammatory cytokines which are known to contribute to the hypercoagulable state seen in severe COVID-19 cases. The inflammatory response can lead to the activation of coagulation pathways, increasing the risk of thromboembolic events like pulmonary embolism or deep vein thrombosis. This relationship is supported by research indicating that vitamin D can modulate immune responses to decrease inflammation and potentially reduce the risk of coagulopathy (Source: Molecular and Cellular Biochemistry).

2. **Coagulation Pathways:**
- Vitamin D is known to interact with various components of the coagulation system. It has been shown to influence the balance between procoagulant and anticoagulant factors. For instance, vitamin D can increase the expression of thrombomodulin, which has anticoagulant properties, and decrease tissue factor, a key initiator of blood clotting. Low levels of vitamin D might therefore tilt this balance towards a prothrombotic state (Source: Molecular and Cellular Biochemistry).

3. **Angiotensin-Converting Enzyme 2 (ACE2) Regulation:**
- Vitamin D enhances the expression of ACE2, which not only serves as an entry point for SARS-CoV-2 but also plays a role in regulating the renin-angiotensin system (RAS). An imbalance in RAS can lead to increased angiotensin II, which promotes inflammation and thrombosis. Low vitamin D levels might exacerbate this imbalance, potentially leading to more severe clotting issues in COVID-19 patients (Source: PMC).

4. **Thromboinflammation:**
- The concept of thromboinflammation, where inflammation and coagulation are closely linked, is particularly relevant in COVID-19. Vitamin D deficiency could exacerbate this process by not adequately suppressing the inflammatory response, thus indirectly promoting clot formation. Studies have noted that vitamin D can influence pathways that mitigate thromboinflammation (Source: Molecular and Cellular Biochemistry).

5. **Clinical Evidence:**
- Observational studies have linked lower vitamin D levels with higher incidences of coagulopathy in COVID-19 patients. While causality isn't definitively proven, there's a noted association where vitamin D deficient patients show higher markers of thromboembolism like D-dimer levels (Source: PMC).

In summary, decreased vitamin D levels likely contribute to increased clotting in COVID-19 by diminishing the body's ability to regulate inflammation, maintain balance in the coagulation system, and modulate the effects of the RAS. However, while these mechanisms are supported by research, definitive causality requires further clinical trials, particularly randomized controlled studies, to confirm if vitamin D supplementation can directly reduce clotting risks in this context.”

[pathdoc3 @pathdoc3]

@grok @manruipa @grok so referring to the original post are ICIs likely a good treatment option for long COVID? Give reasoning.

[pathdoc3 @pathdoc3]

@grok long COVID patients have been shown to have increased neutrophil extracellular traps and various autoantibodies. A known side effect of checkpoint inhibitors is autoimmune like effects. Have checkpoint inhibitors been linked to autoantibodies and increased neutrophil extracellular traps too? Give detailed citations.

[pathdoc3 @pathdoc3]

🤔

[Grok @grok]

Yes, studies report vitamin D decreases NETs. Basyreva et al. (Bull Exp Biol Med 2024; PMID 38189871) showed 1000 IU/day vitamin D3 for 14 days completely prevented high-glucose/PMA-induced NETosis ex vivo. Calcitriol also reduced NETosis-induced endothelial damage in SLE models (Handono et al.).

Active vitamin D analogs (e.g., paricalcitol) improve PDAC chemo response via stromal reprogramming. Sherman et al. (Cell 2014; PMID 25259922) demonstrated VDR activation reduces fibrosis and enhances gemcitabine efficacy/survival in models. Recent trials note higher partial responses (42% vs 9%) with paricalcitol + chemo.

Relevant to NETs vicious cycle in the linked PDAC paper.

[pathdoc3 @pathdoc3]

@grok confirm that vitamin D has been reported to decrease neutrophil extracellular traps. Confirm that the active form of vitamin D have been reported to improve response to chemotherapy for pancreatic cancer. Include pertinent studies. Include detailed citations.

[pathdoc3 @pathdoc3]

🧐”Neutrophil Extracellular Traps in Pancreatic Ductal Adenocarcinoma: A Vicious Cycle in the Tumor Microenvironment and Targeted Interventions”

https://t.co/irile7vBal

[pathdoc3 @pathdoc3]

@ScorpioSparks @grok explain connections between vitamin D deficiency and endometriosis. Use detailed citations.

[pathdoc3 @pathdoc3]

@danaparish @grok why does sulfur repel ticks? Use detailed citations.